SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA.
SARS-CoV-2
cats
dogs
neutralizing antibodies
reverse zoonosis
virus isolation
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
19 05 2021
19 05 2021
Historique:
received:
16
04
2021
revised:
12
05
2021
accepted:
15
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
2
7
2021
Statut:
epublish
Résumé
Understanding the ecological and epidemiological roles of pets in the transmission of SARS-CoV-2 is critical for animal and human health, identifying household reservoirs, and predicting the potential enzootic maintenance of the virus. We conducted a longitudinal household transmission study of 76 dogs and cats living with at least one SARS-CoV-2-infected human in Texas and found that 17 pets from 25.6% of 39 households met the national case definition for SARS-CoV-2 infections in animals. This includes three out of seventeen (17.6%) cats and one out of fifty-nine (1.7%) dogs that were positive by RT-PCR and sequencing, with the virus successfully isolated from the respiratory swabs of one cat and one dog. Whole-genome sequences of SARS-CoV-2 obtained from all four PCR-positive animals were unique variants grouping with genomes circulating among people with COVID-19 in Texas. Re-sampling showed persistence of viral RNA for at least 25 d-post initial test. Additionally, seven out of sixteen (43.8%) cats and seven out of fifty-nine (11.9%) dogs harbored SARS-CoV-2 neutralizing antibodies upon initial sampling, with relatively stable or increasing titers over the 2-3 months of follow-up and no evidence of seroreversion. The majority (82.4%) of infected pets were asymptomatic. 'Reverse zoonotic' transmission of SARS-CoV-2 from infected people to animals may occur more frequently than recognized.
Identifiants
pubmed: 34069453
pii: v13050938
doi: 10.3390/v13050938
pmc: PMC8159091
pii:
doi:
Substances chimiques
Antibodies, Neutralizing
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CDC HHS
ID : RFP 75D 301-20-R-68167
Pays : United States
Organisme : Texas A&M AgriLife Research
ID : NA
Organisme : NIAID NIH HHS
ID : K01 AI128005
Pays : United States
Commentaires et corrections
Type : UpdateOf
Références
Emerg Infect Dis. 2020 Dec;26(12):3069-3071
pubmed: 32788033
Vet Pathol. 2020 Sep;57(5):653-657
pubmed: 32663073
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):710-713
pubmed: 32525853
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Emerg Infect Dis. 2021 Apr;27(4):1015-1022
pubmed: 33770472
EBioMedicine. 2021 Feb;64:103230
pubmed: 33530000
J Gen Virol. 2003 Oct;84(Pt 10):2735-2744
pubmed: 13679608
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Emerg Infect Dis. 2020 Dec;26(12):3071-3074
pubmed: 32938527
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24790-24793
pubmed: 32948692
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
BMC Genomics. 2016 Sep 05;17:708
pubmed: 27595578
Nature. 2020 Oct;586(7831):776-778
pubmed: 32408337
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):244-250
pubmed: 32362649
Emerg Infect Dis. 2021 May 12;27(7):
pubmed: 33979566
Microbiol Resour Announc. 2020 May 28;9(22):
pubmed: 32467283
Nat Commun. 2020 Dec 4;11(1):6231
pubmed: 33277505
Emerg Microbes Infect. 2020 Dec;9(1):2322-2332
pubmed: 33028154
Viruses. 2021 Feb 23;13(2):
pubmed: 33672217
mBio. 2020 Oct 13;11(5):
pubmed: 33051368
Emerg Microbes Infect. 2020 Dec;9(1):2013-2019
pubmed: 32867625
Emerg Infect Dis. 2020 Aug;26(8):
pubmed: 32396505
J Virol Methods. 2018 Jun;256:116-122
pubmed: 29499225
Vet Rec. 2014 Jan 25;174(4):85-91
pubmed: 24464377
One Health. 2020 Dec;10:100164
pubmed: 32904469
Transbound Emerg Dis. 2020 Nov;67(6):2324-2328
pubmed: 32500944
Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26382-26388
pubmed: 32994343
Curr Biol. 2020 Jun 8;30(11):2196-2203.e3
pubmed: 32416074
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156330
Transbound Emerg Dis. 2020 Jul;67(4):1745-1749
pubmed: 32303108